The Evidence Based Rheumatology Podcast podcast

E121: Obinutuzumab in SLE-LN

0:00
18:14
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965

Fler avsnitt från "The Evidence Based Rheumatology Podcast"